About this Journal Submit a Manuscript Table of Contents
Advances in Urology
Volume 2014 (2014), Article ID 203854, 5 pages
http://dx.doi.org/10.1155/2014/203854
Clinical Study

Is Metabolic Syndrome Truly a Risk Factor for Male Lower Urinary Tract Symptoms or Just an Epiphenomenon?

1Faculty of Medicine, Pontifical Catholic University of Campinas (PUC-Campinas), 13060-904 Campinas, SP, Brazil
2Paulínia Municipal Hospital, 13140-295 Paulínia, SP, Brazil
3Faculty of Medicine and Urology Division, University of Campinas (Unicamp), 13083-887 Campinas, SP, Brazil

Received 19 July 2013; Revised 6 December 2013; Accepted 7 December 2013; Published 23 January 2014

Academic Editor: M. Hammad Ather

Copyright © 2014 Marina Zamuner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Lukacs, J. N. Cornu, M. Aout, et al., “Management of lower urinary tract symptoms related to benign prostatic hyperplasia in real-life practice in france: a comprehensive population study,” European Urology, vol. 64, no. 3, pp. 493–501, 2013.
  2. A. A. Yassin, A. I. El-Sakka, F. Saad, and L. J. G. Gooren, “Lower urinary-tract symptoms and testosterone in elderly men,” World Journal of Urology, vol. 26, no. 4, pp. 359–364, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Barzilai, D. M. Huffman, R. H. Muzumdar, and A. Bartke, “The critical role of metabolic pathways in aging,” Diabetes, vol. 61, no. 6, pp. 1315–1322, 2012.
  4. R. Rosen, J. Altwein, P. Boyle et al., “Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7),” European Urology, vol. 44, no. 6, pp. 637–649, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. M. J. Barry, F. J. Fowler Jr., M. P. O'Leary et al., “The American Urological Association symptom index for benign prostatic hyperplasia,” Journal of Urology, vol. 148, no. 5 I, pp. 1549–1557, 1992. View at Scopus
  6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, “Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III),” The Journal of the American Medical Association, vol. 285, no. 19, pp. 2486–2497, 2001. View at Scopus
  7. C. De Nunzio, W. Aronson, S. J. Freedland, E. Giovannucci, and J. K. Parsons, “The correlation between metabolic syndrome and prostatic diseases,” European Urology, vol. 61, no. 3, pp. 560–570, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Kupelian, K. T. McVary, S. A. Hall et al., “Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston area community health survey,” Journal of Urology, vol. 182, no. 2, pp. 616–625, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. T. K. Yang, J. T. Hsieh, S. C. Chen, H. C. Chang, H. J. Yang, and K. H. Huang, “Metabolic syndrome associated with reduced lower urinary tract symptoms in middle-aged men receiving health checkup,” Urology, vol. 80, no. 5, pp. 1093–1097, 2012.
  10. K. Ohgaki, N. Hikima, K. Horiuchi, and Y. Kondo, “Association between metabolic syndrome and male lower urinary tract symptoms in Japanese subjects using three sets of criteria for metabolic syndrome and international prostate symptom score,” Urology, vol. 77, no. 6, pp. 1432–1438, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Temml, R. Obermayr, M. Marszalek, M. Rauchenwald, S. Madersbacher, and A. Ponholzer, “Are lower urinary tract symptoms influenced by metabolic syndrome?” Urology, vol. 73, no. 3, pp. 544–548, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Gao, M. Wang, H. Zhang et al., “Are metabolic syndrome and its components associated with lower urinary tract symptoms? Results from a Chinese male population survey,” Urology, vol. 79, no. 1, pp. 194–201, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. C. C. Wang, M. B. Chancellor, J. M. Lin, J. H. Hsieh, and H. J. Yu, “Type 2 diabetes but not metabolic syndrome is associated with an increased risk of lower urinary tract symptoms and erectile dysfunction in men aged <45 years,” BJU International, vol. 105, no. 8, pp. 1136–1140, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Abdollah, A. Briganti, N. Suardi et al., “Metabolic syndrome and benign prostatic hyperplasia: evidence of a potential relationship, hypothesized etiology, and prevention,” Korean Journal of Urology, vol. 52, no. 8, pp. 507–516, 2011. View at Scopus
  15. S.-O. Andersson, B. Rashidkhani, L. Karlberg, A. Wolk, and J.-E. Johansson, “Prevalence of lower urinary tract symptoms in men aged 45-79 years: a population-based study of 40 000 Swedish men,” BJU International, vol. 94, no. 3, pp. 327–331, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. R. B. Ervin, “Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003–2006,” National Health Statistics Reports, no. 13, pp. 1–7, 2009. View at Scopus
  17. S. Rohrmann, E. Smit, E. Giovannucci, and E. A. Platz, “Associations of obesity with lower urinary tract symptoms and noncancer prostate surgery in the Third National Health and Nutrition Examination Survey,” American Journal of Epidemiology, vol. 159, no. 4, pp. 390–397, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. K. M. Flegal, D. Carroll, B. K. Kit, and C. L. Ogden, “Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010,” The Journal of the American Medical Association, vol. 307, no. 5, pp. 491–497, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. A. D. Sumner, G. L. Sardi, and J. F. Reed III, “Components of the metabolic syndrome differ between young and old adults in the US population,” The Journal of Clinical Hypertension, vol. 14, no. 8, pp. 502–506, 2012.
  20. C. Ozden, O. L. Ozdal, G. Urgancioglu, H. Koyuncu, S. Gokkaya, and A. Memis, “The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia,” European Urology, vol. 51, no. 1, pp. 199–206, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. O. Demir, K. Akgul, Z. Akar et al., “Association between severity of lower urinary tract symptoms, erectile dysfunction and metabolic syndrome,” Aging Male, vol. 12, no. 1, pp. 29–34, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. C.-S. Eom, J.-H. Park, B.-L. Cho, H.-C. Choi, M.-J. Oh, and H.-T. Kwon, “Metabolic syndrome and accompanying hyperinsulinemia have favorable effects on lower urinary tract symptoms in a generally healthy screened population,” Journal of Urology, vol. 186, no. 1, pp. 175–179, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. M. P. Leitão and I. S. Martins, “Prevalence and factors associated with metabolic syndrome in users of primary healthcare units in São Paulo—SP, Brazil,” Revista da Associação Médica Brasileira, vol. 58, no. 1, pp. 60–69, 2012.